RSLV-132 moves into phase III for Sjogren syndrome after reduced fatigue seen in phase II June 25, 2019
GSK initiates phase III trials of GSK-3196165 in moderate to severely active rheumatoid arthritis June 20, 2019
Miransertib studied in patients with PIK3CA-related overgrowth spectrum and Proteus syndrome June 19, 2019
RSS